Cell-penetrating peptide-conjugated antisense PNAs targeting ftsZ and efaA genes eliminated Enterococcus faecalis growth and reduced biofilm formation by 95% without mammalian cell toxicity.
95% biofilm reductionCPP-conjugated anti-efaA PNAs nearly eliminated biofilm formation in Enterococcus faecalis
What the researchers found
Anti-ftsZ PNAs completely inhibited E. faecalis growth, while CPP-conjugated anti-efaA PNAs reduced efaA gene expression and biofilm formation by 95%, with no mammalian cell toxicity.
Why it matters
Antibiotic-resistant Enterococcus is a growing hospital threat. Gene-targeted PNA approaches could provide precision antimicrobials that bypass conventional resistance mechanisms.
The numbers in context
Anti-ftsZ: eliminated growth; anti-efaA: 95% reduction in expression and biofilm; no MCF7 toxicity
How the study worked
In-vitro study using antisense PNAs targeting ftsZ and efaA genes in E. faecalis ATCC 29212, with electroporation and CPP delivery, measuring growth inhibition, biofilm formation, gene expression, and cytotoxicity.
Who was studied
E. faecalis ATCC 29212 treated with anti-ftsZ and CPP-conjugated anti-efaA PNAs
What this study cannot tell us
In-vitro study with a single bacterial strain; electroporation is not clinically viable for ftsZ delivery; CPP-PNA delivery needs in-vivo testing; manufacturing scalability not addressed.
How to read the evidence
Strong in-vitro proof of concept with gene expression validation and cytotoxicity testing, but limited to one bacterial strain and in-vitro conditions.
When this study was published
Published in 2020; antisense PNA antimicrobials remain an active area of research for combating antibiotic-resistant infections.
The bigger picture
This represents a paradigm shift from conventional antibiotics to gene-targeted antimicrobials, using CPP delivery to silence essential bacterial genes — potentially overcoming the antibiotic resistance crisis.
Questions still open
- Can CPP-PNA conjugates be effective against antibiotic-resistant Enterococcus strains in vivo?
- How do CPP-PNA antimicrobials compare in cost and scalability to conventional antibiotics?
- Could this approach be broadened to target other nosocomial pathogens?
Common questions
What are peptide nucleic acids (PNAs)?
How do CPP-PNAs fight antibiotic-resistant bacteria?
Read the original research
Antisense peptide nucleic acids againstftsZ andefaA genes inhibit growth and biofilm formation of Enterococcusfaecalis.
Microbial pathogenesis, 139, 103907
Citation
Narenji, Hanar; Teymournejad, Omid; Rezaee, Mohammad Ahangarzadeh; Taghizadeh, Sepehr; Mehramuz, Bahareh; Aghazadeh, Mohammad; Asgharzadeh, Mohammad; Madhi, Masoumeh; Gholizadeh, Pourya; Ganbarov, Khudaverdi; Yousefi, Mehdi; Pakravan, Asrin; Dal, Tuba; Ahmadi, Raman; Samadi Kafil, Hossein. (2020). Antisense peptide nucleic acids againstftsZ andefaA genes inhibit growth and biofilm formation of Enterococcusfaecalis.. Microbial pathogenesis, 139, 103907. https://doi.org/10.1016/j.micpath.2019.103907